Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-23

Clinical Trial Update: Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating safety and efficacy of RM-131 for anorexia nervosa has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RM-131

Snippet

Sponsor: Motus Therapeutics, Inc. | Conditions: Anorexia Nervosa | Phase 2 | Status: COMPLETED